An experimental model for therapeutic trials of anthelminthic drugs

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.

ESMO open·2026

Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer.

ESMO open·2026

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

ESMO open·2026

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

ESMO open·2026

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.

ESMO real world data and digital oncology·2026

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.

The Journal of antimicrobial chemotherapy·2026

BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.

The Journal of antimicrobial chemotherapy·2026

Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.

The Journal of antimicrobial chemotherapy·2026

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

The Journal of antimicrobial chemotherapy·2026

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

The Journal of antimicrobial chemotherapy·2026

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

The Journal of antimicrobial chemotherapy·2026

Biomphalaria glabrata as a possible experimental model for investigating anti-inflammatory substances.

Biochemistry and biophysics reports·2026

Expanding the host range: Dirofilaria immitis and Crenosoma vulpis identified by morphological and molecular methods in brown bears (Ursus arctos) from Romania.

Veterinary parasitology, regional studies and reports·2026

A Fatal Case of Rat-Bite Fever: A Mechanical Circulatory Support Conundrum.

JACC. Case reports·2026

Fatal Canine Distemper Virus Infections in Free-Ranging Black-Tufted Marmosets (Callithrix penicillata) in Central Brazil.

Journal of wildlife diseases·2026

Assessment of Trypanosoma cruzi Infection Status in White-Eared Opossums (Didelphis albiventris) of the Metropolitan Area of Mendoza, Argentina.

Journal of wildlife diseases·2026

The genome sequence of the Eurasian common lizard, Zootoca vivipara (von Jacquin, 1787) (Squamata: Lacertidae).

Wellcome open research·2026

Related Experiment Videos

An experimental model for therapeutic trials of anthelminthic drugs

Related Concept Videos

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.

Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer.

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.

Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.

BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.

Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

Biomphalaria glabrata as a possible experimental model for investigating anti-inflammatory substances.

Expanding the host range: Dirofilaria immitis and Crenosoma vulpis identified by morphological and molecular methods in brown bears (Ursus arctos) from Romania.

A Fatal Case of Rat-Bite Fever: A Mechanical Circulatory Support Conundrum.

Fatal Canine Distemper Virus Infections in Free-Ranging Black-Tufted Marmosets (Callithrix penicillata) in Central Brazil.

Assessment of Trypanosoma cruzi Infection Status in White-Eared Opossums (Didelphis albiventris) of the Metropolitan Area of Mendoza, Argentina.

The genome sequence of the Eurasian common lizard, Zootoca vivipara (von Jacquin, 1787) (Squamata: Lacertidae).

Related Experiment Videos

An experimental model for therapeutic trials of anthelminthic drugs

Abstract:

Related Concept Videos

Related Articles